Healthcare - Medical - Devices - NASDAQ - US
$ 38.72
1.65 %
$ 552 M
Market Cap
-47.22
P/E
INCOME STATEMENT
126 M
REVENUE
-5.64 M
OPERATING INCOME
-11.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Surmodics, Inc.
| Revenue | 126 M |
| Cost Of Revenue | 33 M |
| Gross Profit | 93.1 M |
| Operating Expenses | 98.7 M |
| Operating Income | -5.64 M |
| Other Expenses | 5.9 M |
| Net Income | -11.5 M |
Income Statement
Millions
| Sep-2024 | Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | Sep-2018 | Sep-2017 | Sep-2016 | Sep-2015 | Sep-2014 | Sep-2013 | Sep-2012 | Sep-2011 | Sep-2010 | Sep-2009 | Sep-2008 | Sep-2007 | Sep-2006 | Sep-2005 | Sep-2004 | Sep-2003 | Sep-2002 | Sep-2001 | Sep-2000 | Sep-1999 | Sep-1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||||
| Revenue | 126.1 | 132.6 | 100.0 | 105.1 | 94.9 | 100.1 | 81.3 | 73.1 | 71.4 | 61.9 | 57.4 | 56.1 | 51.9 | 67.8 | 69.9 | 121.5 | 97.1 | 73.2 | 69.9 | 62.4 | 49.7 | 43.2 | 29.5 | 22.7 | 18.3 | 13.5 | 9.8 |
| GROSS PROFIT | |||||||||||||||||||||||||||
| Cost Of Revenue | 33.0 | 71.6 | 71.0 | 63.9 | 65.5 | 66.5 | 55.0 | 43.2 | 29.4 | 24.8 | 23.6 | 23.0 | 7.4 | 8.3 | 27.6 | 7.5 | 8.5 | 5.6 | 3.4 | 2.9 | 3.0 | 2.6 | 2.7 | 2.4 | 0.7 | 0.7 | 0.5 |
| Gross Profit | 93.1 | 61.0 | 29.0 | 41.2 | 29.4 | 33.6 | 26.4 | 29.9 | 42.0 | 37.1 | 33.9 | 33.2 | 44.5 | 59.5 | 42.3 | 114.0 | 88.6 | 67.6 | 66.5 | 59.5 | 46.7 | 40.6 | 26.8 | 20.3 | 17.6 | 12.8 | 9.3 |
| OPERATING INCOME | |||||||||||||||||||||||||||
| Operating Expenses | 98.7 | 55.4 | 51.1 | 33.5 | 30.6 | 26.4 | 26.6 | 22.9 | 20.4 | 18.0 | 15.3 | 13.9 | 28.2 | 51.2 | 36.4 | 54.8 | 61.3 | 42.1 | 30.3 | 26.3 | 36.2 | 19.9 | 16.1 | 12.7 | 12.3 | 10.3 | 8.3 |
| Selling, General and Administrative Expenses | 56.8 | 51.9 | 46.9 | 30.7 | 28.4 | 23.9 | 24.1 | 20.5 | 18.0 | 18.0 | 15.3 | 13.9 | 14.0 | 20.5 | 18.5 | 30.4 | 20.8 | 13.6 | 9.9 | 7.7 | 7.1 | 8.2 | 6.4 | 4.7 | 4.2 | 4.3 | 3.1 |
| Research and Development Expenses | 10.0 | 9.6 | 9.1 | 46.7 | 50.2 | 52.9 | 41.0 | 31.8 | 18.5 | 16.2 | 15.6 | 15.1 | 14.1 | 30.7 | 17.9 | 24.4 | 40.5 | 28.5 | 20.4 | 16.1 | 12.6 | 11.8 | 9.7 | 8.0 | 6.8 | 5.2 | 4.5 |
| Operating Income | (5.6) | 5.2 | (22.1) | 6.7 | (1.3) | 6.5 | (8.8) | 7.1 | 16.9 | 19.1 | 18.6 | 18.8 | 16.3 | (17.5) | (14.1) | 57.5 | 27.3 | 9.9 | 36.2 | 3.0 | 10.5 | 20.6 | 10.7 | 7.6 | 5.3 | 2.5 | 1.0 |
| PRE-TAX INCOME | |||||||||||||||||||||||||||
| Interest Income Expense | 0 | 3.5 | 0.6 | 0.3 | 0.1 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (1.9) | (2.7) | (0.4) | (0.4) | (0.2) | 1.1 | 1.3 | 70 K | 89 K | (0.8) | (0.1) | 1.5 | 36 K | (32.0) | (6.6) | 2.0 | (0.4) | 4.8 | (0.6) | 1.4 | 1.2 | (6.7) | (2.9) | 3.1 | 1.4 | 1.1 | 0.7 |
| Pre-Tax Income | (7.5) | 2.5 | (22.5) | 6.3 | (1.5) | 7.6 | (7.5) | 7.0 | 16.9 | 19.7 | 18.5 | 20.4 | 16.3 | (16.5) | (20.7) | 59.5 | 26.9 | 14.7 | 35.6 | 4.3 | 11.8 | 22.5 | 12.4 | 10.6 | 6.7 | 3.6 | 1.7 |
| NET INCOME | |||||||||||||||||||||||||||
| Tax Provision | 4.0 | 4.0 | 4.8 | 2.1 | (2.6) | 34 K | (3.1) | 3.1 | 7.0 | 6.3 | 6.3 | 5.8 | 6.2 | (3.7) | 0.4 | 22.0 | 12.2 | 11.3 | 15.2 | 12.6 | 4.4 | 8.6 | 4.6 | 3.8 | 2.5 | (0.8) | (0.6) |
| Net Income | (11.5) | (1.5) | (27.3) | 4.2 | 1.1 | 7.6 | (4.5) | 3.9 | 10.0 | 13.4 | 12.0 | 15.2 | 10.2 | (12.8) | (21.1) | 37.5 | 14.7 | 3.3 | 20.3 | (8.2) | 7.4 | 13.9 | 7.8 | 5.1 | 4.2 | 4.4 | 1.6 |
| EPS | 0.82 | 0.11 | 1.96 | 0.31 | 0.0829 | 0.57 | 0.34 | 0.3 | 0.77 | 1.03 | 0.88 | 1.05 | 0.59 | 0.73 | 1.21 | 2.15 | 0.82 | 0.19 | 1.1 | 0.45 | 0.41 | 0.8 | 0.46 | 0.31 | 0.14 | 0.15 | 0.13 |